Imgatuzumab

Source: Wikipedia, the free encyclopedia.
Imgatuzumab
Humanized (from rat)
TargetEGFR
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6434H9942N1718O2016S44
Molar mass145028.96 g·mol−1

Imgatuzumab (

immunomodulator.[2][3]

The drug was developed by

Roche
.

References

  1. PMID 28467975
    .
  2. ^ World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107" (PDF). WHO Drug Information. 26 (2).
  3. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Imgatuzumab, American Medical Association.


Retrieved from "https://en.wikipedia.org/w/index.php?title=Imgatuzumab&oldid=1155757193"